Table 1.
Clinical characteristics of study population (n=80)
Clinical variables | Mean ± standard deviation or n (%) | Range |
---|---|---|
Race* | ||
Caucasian | 77 (97.5) | |
Non-Caucasian | 2 (2.5) | |
Sex | ||
Male | 53 (66.2) | |
Female | 27 (33.8) | |
Age, years | 70 ± 8 | (51 – 85) |
Body mass index – kg/m2 | 28 ± 6 | (18 – 58) |
Smoker | 50 (62.5) | |
Hypertension | 61 (76.2) | |
Hyperlipidemia | 71 (88.8) | |
Diabetes | 9 (11.2) | |
Coronary artery disease | 22 (27.5) | |
Peripheral artery disease | 18 (22.5) | |
Antihypertensive use | 63 (78.8) | |
Statin use | 65 (81.2) | |
Antiplatelet use | 64 (80.0) | |
Anticoagulant use | 1 (1.2) |
One subject was excluded due to a missing value for race.